(Q44848583)

6 December 2017

title

Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol (English)

1 reference

6 December 2017

Bradley T Christian

1

1 reference

6 December 2017

Tanjore Narayanan

2

1 reference

6 December 2017

Bing Shi

3

1 reference

6 December 2017

Evan D Morris

4

1 reference

6 December 2017

Joseph Mantil

5

1 reference

6 December 2017

Jogeshwar Mukherjee

6

1 reference

6 December 2017

publication date

1 March 2004

1 reference

Journal of Cerebral Blood Flow & Metabolism

6 December 2017

published in

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

309-322

1 reference

A new look at the statistical model identification

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Compartmental Analysis of Diprenorphine Binding to Opiate Receptors in the Rat in vivo and its Comparison with Equilibrium Data in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Absolute quantification by positron emission tomography of the endogenous ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Preparation of [76Br]FLB 457 and [76Br]FLB 463 for examination of striatal and extrastriatal dopamine D-2 receptors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Optimal experiment design for PET quantification of receptor concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

Limbic selectivity of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.WCB.0000105020.93708.DD

10.1097/01.WCB.0000105020.93708.DD

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 December 2017

1030900610

0 references

1 reference